Innate immune processes in lupus erythematosus

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• The innate immune system is crucial in systemic autoimmune diseases, including systemic lupus erythematosus (SLE) and dermatomyositis.
• The roles of complement factors and Toll-like receptors (TLRs) in autoimmunity are well-established.
• Interferon-alpha (IFNα) plays a key role, initiating positive feedback loops that perpetuate autoimmune responses.

Purpose of the Study:

• To explore the role of innate immune system activation in systemic autoimmune diseases.
• To investigate the connection between genetic mutations affecting nucleic acid handling and increased IFNα production.
• To propose a new classification for diseases bridging autoinflammation and autoimmunity.

Main Methods:

• Review of genetic and clinical evidence for complement factors and TLRs.
• Analysis of immune complex activation of TNF and IFNα.
• Examination of mutations in genes related to intracellular RNA and DNA handling.

Main Results:

• Mutations in nucleic acid-handling enzymes lead to elevated IFNα levels.
• These mutations are associated with familial chilblain lupus and SLE.
• These conditions represent a spectrum between autoinflammation and autoimmunity.

Conclusions:

• Increased IFNα due to genetic mutations contributes to autoimmune pathogenesis.
• A new term, "autoadjuvant," is proposed for conditions where innate immune activation lowers the threshold for autoimmune reactions.
• Understanding these mechanisms is vital for developing targeted therapies for systemic autoimmune diseases.